Topic Review
Tubal Endometriosis
Tubal endometriosis (EM) refers to the detection of ectopic endometrial implants on tubes. It may cause a significant defect of the tubes, translating into dysmenorrhea, pelvic pain, and infertility.
  • 406
  • 08 Mar 2022
Topic Review
Treatment of Vulvovaginal Atrophy
Vulvovaginal atrophy (VVA) is a chronic progressive disease involving the female genital apparatus and lower urinary tract. This condition is related to hypoestrogenism consequent to menopause onset but is also due to the hormonal decrease after adjuvant therapy for patients affected by breast cancer. Considering the high prevalence of VVA and the expected growth of this condition due to the increase in the average age of the female population, it is easy to understand its significant social impact. VVA causes uncomfortable disorders, such as vaginal dryness, itching, burning, and dyspareunia, and requires constant treatment, on cessation of which symptoms tend to reappear. 
  • 357
  • 14 Jun 2022
Topic Review
Treatment of Peripartum Depression with Antidepressants
Peripartum or perinatal depression, which is depression arising in the period between the start of a pregnancy and the end of the first postpartum year. Multiple CPGs recommend antidepressant initiation or continuation based on maternal disease severity, non-response to first-line non-pharmacological interventions, and after risk-benefit assessment. Advice on treatment of comorbid anxiety is largely missing or unspecific. Antidepressant dispensing data suggest general prescribers’ compliance with the preferred substances of the CPG, although country-specific differences were noted. To conclude, there is an urgent need for harmonized, up-to-date CPGs for pharmacological management of peripartum depression and comorbid anxiety in Europe. The recommendations need to be informed by the latest available evidence so that healthcare providers and women can make informed, evidence-based decisions about treatment choices. 
  • 332
  • 28 Feb 2022
Topic Review
Treatment of Metformin for Endometriosis
Endometriosis is a common disease in women of reproductive age, and its pathogenesis seems to be largely affected by hormone imbalance, inflammation, oxidative stress, and autophagy dysregulation.  Metformin is an insulin sensitizer widely used for the treatment of type 2 diabetes mellitus. In endometriosis, metformin might modify the stroma–epithelium communication via Wnt2/β-catenin. With its unique therapeutic mechanisms and no serious side effects, metformin seems to be a helpful anti-inflammatory and anti-proliferative agent in the treatment of endometriosis.
  • 1.3K
  • 11 May 2022
Topic Review
Treatment of Functional Hypothalamic Amenorrhea
Functional hypothalamic amenorrhea (FHA) is a non-organic reversible chronic endocrine disorder characterized by an impaired pulsatile secretion of the gonadotropin-releasing hormone (GnRH) from the hypothalamus. This impaired secretion, triggered by psychosocial and metabolic stressors, leads to an abnormal pituitary production of gonadotropins. As LH and FSH release is defective, the ovarian function is steadily reduced, inducing a systemic hypoestrogenic condition characterized by amenorrhea, vaginal atrophy, mood changes and increased risk of osteoporosis and cardiovascular disease. Diagnosis of FHA is made excluding other possible causes for secondary amenorrhea, and it is based upon the findings of low serum gonadotropins and estradiol (E2) with evidence of precipitating factors (excessive exercise, low weight, stress). Treatments of women with FHA include weight gain through an appropriate diet and physical activity reduction, psychological support, and integrative approach up to estrogen replacement therapy.
  • 272
  • 03 Jul 2023
Topic Review
Treat Preeclampsia by Targeting NFĸB by Drugs
Preeclampsia (PE) is characterised by high levels and activity of the transcription factor Nuclear Factor kappa B (NFĸB) in the maternal blood and placental cells. This factor is responsible for the regulation of over 400 genes known to influence processes related to inflammation, apoptosis and angiogenesis, and cellular responses to oxidative stress and hypoxia. Although high NFĸB activity induces hypoxia and inflammation, which are beneficial for the process of implantation, NFĸB level should be reduced in the later stages of physiological pregnancy to favour maternal immunosuppression and maintain gestation. It is believed that the downregulation of NFĸB activity by pharmacotherapy might be a promising way to treat preeclampsia. 
  • 590
  • 10 May 2022
Topic Review
Transvaginal Ultrasound as Technique for Diagnosis of Endometriosis
Transvaginal ultrasound (TVUS) is surely the first-line technique for the diagnosis of endometriosis. The possibility to perform a dynamic ultrasonographic examination can provide additional information that is not easily obtained with other imaging modalities.
  • 518
  • 06 Dec 2022
Topic Review
Transvaginal Ultrasound Accuracy in the Hydrosalpinx Diagnosis
Hydrosalpinx is a condition with a crucial prognostic role in reproduction, and its diagnosis by a non-invasive technique such as ultrasound is key in achieving an adequate reproductive assessment while avoiding unnecessary laparoscopies. 
  • 396
  • 15 May 2023
Topic Review
Transplacental Treatment of Fetal Tachyarrhythmia
Fetal arrhythmias are diagnosed in 1–3% of pregnancies. Despite this, they account for up to 20% of consultations related to fetal congenital heart disease in referral units. Among rhythm disorders, fetal tachyarrhythmias affect approximately 0.1% of pregnancies.
  • 220
  • 11 May 2023
Topic Review
Transkingdom Analysis of the Female Reproductive Tract
The female reproductive tract (FRT) microbiome plays a vital role in maintaining vaginal health. Viruses are key regulators of other microbial ecosystems, but little is known about how the FRT viruses (virome), particularly bacteriophages that comprise the phageome, impact FRT health and dysbiosis. 
  • 287
  • 30 Mar 2022
  • Page
  • of
  • 33